Back to Search Start Over

Ptrf transgenic mice exhibit obesity and fatty liver.

Authors :
Li, Qian
Bai, Lin
Shi, Guiying
Zhang, Lianfeng
Dai, Yifan
Liu, Pingsheng
Cong, Yu‐Sheng
Wang, Miao
Source :
Clinical & Experimental Pharmacology & Physiology. Jul2018, Vol. 45 Issue 7, p704-710. 7p. 4 Graphs.
Publication Year :
2018

Abstract

Summary: Polymerase I and transcript release factor (Ptrf, also known as Cavin1) is an essential component in the biogenesis and function of caveolae. Ptrf knockout mice or patients with PTRF mutations exhibit numerous pathologies including markedly aberrant fuel metabolism, lipodystrophy and muscular dystrophy. In this study, we generated Ptrf transgenic mice to explore its function in vivo. Compared with wild‐type (WT) mice, we found that the Ptrf transgenic mice showed obesity with an increased level of ALT (alanine aminotransferase) and AST (aspartate transaminase). Ptrf transgenic mice exhibited severe fat degeneration and a higher degree of fat accumulation in the liver compared with WT mice. Consistently, we found that the expression of the fat synthesis gene, Fasn, was increased in the liver of Ptrf transgenic mice. Thus, Ptrf transgenic mice would be a good model for investigating the molecular mechanism and therapeutic targets of obesity and fatty liver associated diseases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03051870
Volume :
45
Issue :
7
Database :
Academic Search Index
Journal :
Clinical & Experimental Pharmacology & Physiology
Publication Type :
Academic Journal
Accession number :
130342030
Full Text :
https://doi.org/10.1111/1440-1681.12920